Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.
Azithromycin
/ administration & dosage
Campylobacter
/ drug effects
Campylobacter Infections
/ drug therapy
Child
Child Mortality
Child, Preschool
Drug Resistance, Bacterial
/ drug effects
Gastrointestinal Microbiome
/ drug effects
Gene Expression Regulation, Bacterial
/ drug effects
Humans
Macrolides
/ administration & dosage
Male
Metagenomics
Nigeria
/ epidemiology
Sequence Analysis, RNA
Journal
Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
31
03
2019
accepted:
25
06
2019
pubmed:
14
8
2019
medline:
13
11
2019
entrez:
14
8
2019
Statut:
ppublish
Résumé
The MORDOR I trial
Identifiants
pubmed: 31406349
doi: 10.1038/s41591-019-0533-0
pii: 10.1038/s41591-019-0533-0
doi:
Substances chimiques
Macrolides
0
Azithromycin
83905-01-5
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1370-1376Références
Keenan, J. D. et al. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N. Engl. J. Med. 378, 1583–1592 (2018).
doi: 10.1056/NEJMoa1715474
Jimenez, S. G., Heine, R. G., Ward, P. B. & Robins-Browne, R. M. Campylobacter upsaliensis gastroenteritis in childhood. Pediatr. Infect. Dis. J. 18, 988–992 (1999).
doi: 10.1097/00006454-199911000-00011
Bourke, B., Chan, V. L. & Sherman, P. Campylobacter upsaliensis: waiting in the wings. Clin. Microbiol. Rev. 11, 440–449 (1998).
doi: 10.1128/CMR.11.3.440
Sire, J. M. et al. Community-acquired infectious diarrhoea in children under 5 years of age in Dakar, Senegal. Paediatr. Int. Child Health 33, 139–144 (2013).
doi: 10.1179/2046905512Y.0000000046
Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
doi: 10.1038/nmeth.3589
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
doi: 10.1186/gb-2011-12-6-r60
Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962–968 (2018).
doi: 10.1038/s41592-018-0176-y
Yoshioka, S. & Newell, P. D. Disruption of de novo purine biosynthesis in Pseudomonas fluorescens Pf0-1 leads to reduced biofilm formation and a reduction in cell size of surface-attached but not planktonic cells. PeerJ. 4, e1543 (2016).
doi: 10.7717/peerj.1543
Zhao, H., Patel, V., Helmann, J. D. & Dörr, T. Don’t let sleeping dogmas lie: new views of peptidoglycan synthesis and its regulation. Mol. Microbiol. 106, 847–860 (2017).
doi: 10.1111/mmi.13853
Typas, A., Banzhaf, M., Gross, C. A. & Vollmer, W. From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat. Rev. Microbiol. 10, 123–136 (2011).
doi: 10.1038/nrmicro2677
O’Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553–565 (2016).
doi: 10.1038/nri.2016.70
Doan, T. et al. Macrolide resistance in MORDOR I: a cluster-randomized trial in Niger. N. Engl. J. Med. 380, 2271–2273 (2019).
doi: 10.1056/NEJMc1901535
Oldenburg, C. E. et al. Gut resistome after oral antibiotics in preschool children in BurkinaFaso: a randomized controlled trial. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciz455 (2019).
O’Brien, K. S. et al. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. Lancet Infect. Dis. 19, e14–e25 (2019).
doi: 10.1016/S1473-3099(18)30444-4
Doan, T. et al. Macrolide resistance in MORDOR I - A cluster-randomized trial in Niger. N. Engl. J. Med. 380, 2271–2273 (2019).
doi: 10.1056/NEJMc1901535
McMullan, B. J. & Mostaghim, M. Prescribing azithromycin. Aust. Prescr. 38, 87–89 (2015).
doi: 10.18773/austprescr.2015.030
Engberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P. & Nachamkin, I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7, 24–34 (2001).
doi: 10.3201/eid0701.010104
Nachamkin, I., Ung, H. & Li, M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982–2001. Emerg. Infect. Dis. 8, 1501–1503 (2002).
doi: 10.3201/eid0812.020115
Same, R. G. & Tamma, P. D. Campylobacter infections in children. Pediatr. Rev. 39, 533–541 (2018).
doi: 10.1542/pir.2017-0285
Kotloff, K. L. et al. The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin. Infect. Dis. 55(Suppl 4), S232–S245 (2012).
doi: 10.1093/cid/cis753
Amour, C. et al. Epidemiology and impact of Campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin. Infect. Dis. 63, 1171–1179 (2016).
pubmed: 27501842
pmcid: 5064165
Nachamkin, I. Chronic effects of Campylobacter infection. Microbes Infect. 4, 399–403 (2002).
doi: 10.1016/S1286-4579(02)01553-8
Kotloff, K. L. et al. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS). Lancet Glob. Health 7, e568–e584 (2019).
doi: 10.1016/S2214-109X(19)30076-2
Buss, S. N. et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J. Clin. Microbiol. 53, 915–925 (2015).
doi: 10.1128/JCM.02674-14
Patrick, M. E. et al. Features of illnesses caused by five species of Campylobacter, Foodborne Diseases Active Surveillance Network (FoodNet)—2010–2015. Epidemiol. Infect. 146, 1–10 (2018).
doi: 10.1017/S0950268817002370
Bolinger, H. & Kathariou, S. The current state of macrolide resistance in Campylobacter spp.: trends and impacts of resistance mechanisms. Appl. Environ. Microbiol. 83, e00416-17 (2017).
doi: 10.1128/AEM.00416-17
Founou, L. L., Amoako, D. G., Founou, R. C. & Essack, S. Y. Antibiotic resistance in food animals in Africa: a systematic review and meta-analysis. Microb. Drug Resist. 24, 648–665 (2018).
doi: 10.1089/mdr.2017.0383
Schiaffino, F. et al. Antibiotic resistance of Campylobacter species in a pediatric cohort study. Antimicrob. Agents Chemother. 63, e01911-18 (2019).
doi: 10.1128/AAC.01911-18
Keenan, J. D. et al. Longer-term assessment of azithromycin for reducing childhood mortality in Africa. N. Engl. J. Med. 380, 2207–2214 (2019).
doi: 10.1056/NEJMoa1817213
Doan, T. et al. Gut microbial diversity in antibiotic-naive children after systemic antibiotic exposure: a randomized controlled trial. Clin. Infect. Dis. 64, 1147–1153 (2017).
doi: 10.1093/cid/cix141
Chandramohan, D. et al. Effect of adding azithromycin to seasonal malaria chemoprevention. N. Engl. J. Med. 380, 2197–2206 (2019).
doi: 10.1056/NEJMoa1811400
Amza, A. et al. Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial. PLoS Negl. Trop. Dis. 8, e3128 (2014).
doi: 10.1371/journal.pntd.0003128
Sié, A. et al. Effect of antibiotics on short-term growth among children in Burkina Faso: a randomized trial. Am. J. Trop. Med. Hyg. 99, 789–796 (2018).
doi: 10.4269/ajtmh.18-0342
Amza, A. et al. A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger. Am. J. Trop. Med. Hyg. 88, 138–143 (2013).
doi: 10.4269/ajtmh.2012.12-0284
Doan, T. et al. Mass azithromycin distribution and community microbiome: a cluster-randomized trial. Open Forum Infect. Dis. 5, ofy182 (2018).
doi: 10.1093/ofid/ofy182
Doan, T. et al. Metagenomic DNA sequencing for the diagnosis of intraocular infections. Ophthalmology 124, 1247–1248 (2017).
doi: 10.1016/j.ophtha.2017.03.045
Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150–3152 (2012).
doi: 10.1093/bioinformatics/bts565
Ziv, J. & Lempel, A. A universal algorithm for sequential data compression. IEEE Trans. Inf. Theory 23, 337–343 (1977).
doi: 10.1109/TIT.1977.1055714
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923
Kim, D., Song, L., Breitwieser, F. P. & Salzberg, S. L. Centrifuge: rapid and sensitive classification of metagenomic sequences. Genome Res. 26, 1721–1729 (2016).
doi: 10.1101/gr.210641.116
Lakin, S. M. et al. MEGARes: an antimicrobial resistance database for high throughput sequencing. Nucleic Acids Res. 45, D574–D580 (2017).
doi: 10.1093/nar/gkw1009
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
doi: 10.1093/bioinformatics/btp324
Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb. Genom. 3, e000131 (2017).
pubmed: 29177089
pmcid: 5695208
Gibreel, A. et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49, 2753–2759 (2005).
doi: 10.1128/AAC.49.7.2753-2759.2005
Luangtongkum, T. et al. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4, 189–200 (2009).
doi: 10.2217/17460913.4.2.189
Jost, L. Entropy and diversity. Oikos 113, 363–375 (2006).
doi: 10.1111/j.2006.0030-1299.14714.x
Jost, L. Partitioning diversity into independent alpha and beta components. Ecology 88, 2427–2439 (2007).
doi: 10.1890/06-1736.1